An upcoming case report to be presented at the AACE Annual Meeting will present the case for medical tattoos. As AACE's press release states, "One of the most obvious benefits of medical tattooing is for identification purposes in an emergency situation, especially for patients with diabetes, when a patient may be incapacitated-particularly in... Read more
The Annals of Internal Medicine has recently published a very intriguing article: Differences in Control of Cardiovascular Disease and Diabetes by Race, Ethnicity, and Education: U.S. Trends From 1999 to 2006 and Effects of Medicare Coverage.
The authors reviewed data from the National Health and Nutrition Examination Survey (NHANES)... Read more
A writer for the Associated Press recently described the plight of some folks with diabetes who have had to scrimp on their diabetes care due to the recession, stopping medications or cutting back on testing and doctor's visits because of lack of money. It's sad, to be sure, and there are no easy answers for folks to cope with an expensive... Read more
On April 2 2009, the FDA had an Advisory Committee meeting to discuss Novo-Nordisk's application to sell their new diabetes drug, liraglutide. The FDA routinely turns to Advisory Committees for input about the safety and/or efficacy of drugs they are reviewing, but then the FDA makes the final decision about whether a new drug should be approved... Read more
Yesterday I wrote about my initial very frustrated reaction after learning that Smiths Medical is discontinuing the Cozmo insulin pump. Which I consider a crying shame, as the Deltec Cozmo pump, IMHO, is the best pump out there.
Today, I spoke with several people from Smiths, including Richard Thomas, Vice President, Global Diabetes,... Read more